REMUS
Invest Now
Start SIP in
REMUS
Performance
- Low
- ₹871
- High
- ₹934
- 52 Week Low
- ₹870
- 52 Week High
- ₹1,417
- Open Price₹874
- Previous Close₹879
- Volume8,600
Investment Returns
- Over 1 Month -3.42%
- Over 3 Month -8.91%
- Over 6 Month -19.63%
- Over 1 Year -8.34%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 37.7
- PEG Ratio
- -
- Market Cap Cr
- 1,097
- P/B Ratio
- 4.3
- Average True Range
- 41.79
- EPS
- 24.67
- Dividend Yield
- 0.1
- MACD Signal
- -14.32
- RSI
- 47.32
- MFI
- 57.28
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹930.70
+
52.15
(5.94%)

-
- Bearish Moving Average 12
-
- Bullish Moving Average 4
- 20 Day
- ₹938.79
- 50 Day
- ₹966.90
- 100 Day
- ₹1,003.44
- 200 Day
- ₹1,029.01
Resistance and Support
911.9
- R3 1,015.80
- R2 974.90
- R1 952.80
- S1 889.80
- S2 848.90
- S3 826.80
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-17 | Audited Results, Dividend & Others | To consider 1. Bonus 2. Other business matters. Interim Dividend of Rs. 2 per equity share. |
2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
2024-05-16 | Audited Results | |
2024-04-23 | Bonus issue & Interim Dividend | |
2024-04-22 | Interim Dividend |
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹930 As on 13 July, 2025 | 04:27
The Market Cap of Remus Pharmaceuticals is ₹1096.7 Cr As on 13 July, 2025 | 04:27
The P/E ratio of Remus Pharmaceuticals is 37.7 As on 13 July, 2025 | 04:27
The PB ratio of Remus Pharmaceuticals is 4.3 As on 13 July, 2025 | 04:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.